Sionna Therapeutics, Inc. (SION)
5.59
+0.30
(+5.67%)
USD |
NASDAQ |
Aug 24, 16:00
5.55
-0.04
(-0.72%)
After-Hours: 20:00
Sionna Therapeutics Enterprise Value : 35.96M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 35.96M |
| August 20, 2026 | 46.34M |
| August 19, 2026 | 79.31M |
| August 18, 2026 | 65.31M |
| August 17, 2026 | 63.96M |
| August 14, 2026 | 88.80M |
| August 13, 2026 | 92.41M |
| August 12, 2026 | 79.31M |
| August 11, 2026 | 27.38M |
| August 10, 2026 | 0.2769M |
| August 07, 2026 | 2.102B |
| August 06, 2026 | 2.038B |
| August 05, 2026 | 1.935B |
| August 04, 2026 | 2.053B |
| August 03, 2026 | 2.022B |
| July 31, 2026 | 1.926B |
| July 30, 2026 | 1.910B |
| July 29, 2026 | 1.821B |
| July 28, 2026 | 1.899B |
| July 27, 2026 | 1.847B |
| July 24, 2026 | 1.861B |
| July 23, 2026 | 1.787B |
| July 22, 2026 | 1.831B |
| July 21, 2026 | 1.929B |
| July 20, 2026 | 1.861B |
| Date | Value |
|---|---|
| July 17, 2026 | 2.029B |
| July 16, 2026 | 1.843B |
| July 15, 2026 | 1.801B |
| July 14, 2026 | 1.721B |
| July 13, 2026 | 1.782B |
| July 10, 2026 | 1.843B |
| July 09, 2026 | 1.827B |
| July 08, 2026 | 1.784B |
| July 07, 2026 | 1.826B |
| July 06, 2026 | 1.745B |
| July 02, 2026 | 1.784B |
| July 01, 2026 | 1.678B |
| June 30, 2026 | 1.784B |
| June 29, 2026 | 1.729B |
| June 26, 2026 | 1.694B |
| June 25, 2026 | 1.720B |
| June 24, 2026 | 1.644B |
| June 23, 2026 | 1.589B |
| June 22, 2026 | 1.543B |
| June 18, 2026 | 1.474B |
| June 17, 2026 | 1.448B |
| June 16, 2026 | 1.359B |
| June 15, 2026 | 1.415B |
| June 12, 2026 | 1.411B |
| June 11, 2026 | 1.417B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Vertex Pharmaceuticals, Inc. | 132.96B |
| ACADIA Pharmaceuticals, Inc. | 4.195B |
| Immunic, Inc. | 70.60M |
| Alnylam Pharmaceuticals, Inc. | 31.27B |
| Anika Therapeutics, Inc. | 278.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -29.89M |
| Total Expenses (Quarterly) | 29.89M |
| EPS Diluted (Quarterly) | -0.6619 |
| Earnings Yield | -38.80% |
| Normalized Earnings Yield | -38.80 |